Apeloa Pharmaceutical Competitors and Similar CompaniesClear all
Apeloa Pharmaceutical's competitors and similar companies include EyePoint Pharmaceuticals, SciClone Pharmaceuticals, STADA and Faes Farma.
 Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. |  EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. |  Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials. | ||
Founding Date | Founding Date 1989 | Founding Date 1987 | Founding Date 1989 | Founding Date 1895 | Founding Date 1933 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations CN HQ | Locations Watertown, US HQ | Locations Foster City, US HQ | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Leioa, ES HQ Madrid, ES Atlanta, US |
Employees | Employees 7,060 | Employees 8453% increase | Employees 1102% decrease | Employees 12,33911% increase | Employees 1,775 |
Valuation ($) | Valuation ($) 2.7 b | Valuation ($) 617.6 m | Valuation ($) N/A | Valuation ($) 6 b | Valuation ($) 1.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥9.7b (FY, 2025) | Revenue (est.) $31.4m (FY, 2025) | Revenue (est.) $160.1m (FY, 2016) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) €493.6m (FY, 2024) |
Cost of goods | Cost of goods ¥7.2b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods €1.3b (FY, 2020) | Cost of goods €167.1m (FY, 2024) |
Gross profit | Gross profit ¥2.5b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €1.7b (FY, 2020) | Gross profit €342.9m (FY, 2024) |
Net income | Net income ¥890.7m (FY, 2025) | Net income ($232m) (FY, 2025) | Net income $30.7m (FY, 2016) | Net income €181.9m (FY, 2020) | Net income €111.1m (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
EyePoint Pharmaceuticals
HQ
Watertown, US
Employees
84
EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View company
STADA
HQ
Bad Vilbel, DE
Employees
12,339↑ 11% increase
STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View companyFaes Farma
HQ
Leioa, ES
Employees
1,775
Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials.
View company